Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

F Hirayama

Showing results (1-10 of 129) with videos related to

Pageof 13
Sort By:
Vox Sanguinis|June 15, 2013
Approach of using established and new laboratory tests to more comprehensively investigate noninfectious and nonhemolytic transfusion reactions--along with the experience in JapanF Hirayama
Yakugaku Zasshi : Journal of the Pharmaceutical Society of Japan|June 1, 1993
[Development and pharmaceutical evaluation of hydrophobic cyclodextrin derivatives as modified-release drug carriers]F Hirayama
Blood Cells|January 1, 1994
Cytokine regulation of early B-lymphopoiesis assessed in cultureF Hirayama, M Ogawa
Blood|December 15, 1995
Negative regulation of early T lymphopoiesis by interleukin-3 and interleukin-1 alphaF Hirayama, M Ogawa
Stem Cells (Dayton, Ohio)|July 1, 1996
Cytokine regulation of early lymphohematopoietic developmentF Hirayama, M Ogawa
Nihon Yakurigaku Zasshi. Folia Pharmacologica Japonica|February 24, 2001
[New anticoagulants]T Kawasaki, F Hirayama
International Journal of Hematology|October 1, 1994
CD43 expression by murine lymphohemopoietic progenitorsF Hirayama, M Ogawa
Journal of Medicinal Chemistry|August 15, 1997
6A-O-[(4-biphenylyl)acetyl]-alpha-, -beta-, and -gamma-cyclodextrins and 6A-deoxy-6A-[[(4-biphenylyl)acetyl]amino]-alpha-, -beta-, and -gamma-cyclodextrins: potential prodrugs for colon-specific deliveryK Uekama, K Minami, F Hirayama
Pharmaceutical Research|December 1, 1994
Effect of 2-hydroxypropyl-beta-cyclodextrin on crystallization and polymorphic transition of nifedipine in solid stateF Hirayama, Z Wang, K Uekama
Journal of Pharmaceutical Sciences|September 1, 1992
Acid-catalyzed hydrolysis of maltosyl-beta-cyclodextrinF Hirayama, M Yamamoto, K Uekama
Pageof 13

Showing results (1-10 of 129) with videos related to

Sort By:
Pageof 13
Vox Sanguinis|June 15, 2013
Approach of using established and new laboratory tests to more comprehensively investigate noninfectious and nonhemolytic transfusion reactions--along with the experience in JapanF Hirayama
Yakugaku Zasshi : Journal of the Pharmaceutical Society of Japan|June 1, 1993
[Development and pharmaceutical evaluation of hydrophobic cyclodextrin derivatives as modified-release drug carriers]F Hirayama
Blood Cells|January 1, 1994
Cytokine regulation of early B-lymphopoiesis assessed in cultureF Hirayama, M Ogawa
Blood|December 15, 1995
Negative regulation of early T lymphopoiesis by interleukin-3 and interleukin-1 alphaF Hirayama, M Ogawa
Stem Cells (Dayton, Ohio)|July 1, 1996
Cytokine regulation of early lymphohematopoietic developmentF Hirayama, M Ogawa
Nihon Yakurigaku Zasshi. Folia Pharmacologica Japonica|February 24, 2001
[New anticoagulants]T Kawasaki, F Hirayama
International Journal of Hematology|October 1, 1994
CD43 expression by murine lymphohemopoietic progenitorsF Hirayama, M Ogawa
Journal of Medicinal Chemistry|August 15, 1997
6A-O-[(4-biphenylyl)acetyl]-alpha-, -beta-, and -gamma-cyclodextrins and 6A-deoxy-6A-[[(4-biphenylyl)acetyl]amino]-alpha-, -beta-, and -gamma-cyclodextrins: potential prodrugs for colon-specific deliveryK Uekama, K Minami, F Hirayama
Pharmaceutical Research|December 1, 1994
Effect of 2-hydroxypropyl-beta-cyclodextrin on crystallization and polymorphic transition of nifedipine in solid stateF Hirayama, Z Wang, K Uekama
Journal of Pharmaceutical Sciences|September 1, 1992
Acid-catalyzed hydrolysis of maltosyl-beta-cyclodextrinF Hirayama, M Yamamoto, K Uekama
Pageof 13